Lineage Cell Therapeutics In shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by DAFNA Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.0M | 1.4M | 1.48 |
| 2023-06-30 | $197k | 140k | 1.41 |
| 2023-03-31 | $210k | 140k | 1.50 |
| 2022-12-31 | $164k | 140k | 1.17 |
| 2022-09-30 | $158k | 140k | 1.13 |
| 2022-06-30 | $221k | 140k | 1.58 |
| 2022-03-31 | $216k | 140k | 1.54 |
| 2021-12-31 | $196k | 80k | 2.45 |
| 2021-03-31 | $177k | 75k | 2.35 |
| 2020-12-31 | $141k | 80k | 1.76 |
| 2020-09-30 | $89k | 95k | 0.94 |
| 2020-06-30 | $83k | 95k | 0.87 |
| 2020-03-31 | $79k | 95k | 0.83 |
| 2019-12-31 | $85k | 95k | 0.89 |
| 2019-09-30 | $93k | 95k | 0.98 |